The EAEU Electronic Submission FormatNovember 20, 2019
Ukrainian government simplifies registration of medicines from the U.S., EU and certain other developed countries
On June 16, 2016, the President of Ukraine signed the Amendments to the Medicines Act, which are intended to simplify the procedure of state registration of medicines coming from countries with strong established regulatory requirements, institutions, and procedures. The changes will become effective starting from their official publication day and responsible government agencies must still adjust certain bylaws to implement them.
Extended list of medicines subject to the simplified procedure
Now all medicines (drugs) registered by a competent authority of the USA (i.e., FDA), Switzerland, Canada, Australia, Japan, and the EU are now subject to the simplified registration procedure. Whereas the previous version of the Medicines Act allowed such simplified procedures only for medicines that treat tuberculosis, HIV/AIDS, viral hepatitis, oncological, and rare (orphan) illnesses.
Read Full article HERE.
Meet us at IV All-Russia GMP Conference 2019September 23, 2019
eCTD and eCTDmanager in EAEU and CISJuly 23, 2019
eRA 2019 Conference with CIS Region Partner Meeting in MunichJune 02, 2019
Meet us at Conference RegLek EAEU 2019 in MoscowApril 15, 2019
Digital Pharma - Intelligent Pharmaceutical Enterprise in KievApril 12, 2019
Participation in DIA Europe 2019April 01, 2019
Participation in the CPhI Worldwide 2018November 30, 2018
eRA 2019 conferenceNovember 28, 2018
EMA identifies gaps in industry preparedness for BrexitJuly 27, 2018